bcrx stock forecast zacks

The 10 analysts offering 12-month price forecasts for BioCryst Pharmaceuticals Inc have a median target of 1550 with a high estimate of 3000 and a low. Stock news by MarketWatch.

Biocryst Bcrx Stock Up On Q4 Orladeyo Preliminary Sales

Get the latest BCRX.

. According to 18 stock analysts the average 12-month stock price forecast for BCRX stock is 1867 which predicts an increase of 5008. BioCryst Pharmaceuticals detailed stock quotes stock data Real-Time ECN charts stats and. View real-time stock prices and stock quotes for a full financial overview.

Web Piscataway Weather Forecasts. BCRX Complete BioCryst Pharmaceuticals Inc. This compares to loss of 033.

90756 Upside Based on 1 Wall Street analysts offering 12 month price targets for Baudax Bio in the last 3 months. In the latest trading session Dynavax Technologies. According to 18 analysts the average rating for BCRX stock is Buy The 12-month stock price forecast is 1867 which is an increase of 5455 from the.

The average price target is 200 with. Stock Price Forecast. Web DVAX is currently sporting a Zacks Rank of 2 Buy as well as a Value grade of A.

A value greater than 1 in general is not as good overvalued to its growth rate. For example a company with a PE ratio of 25 and a growth rate of 20 would have a PEG ratio of 125 25. BXRX Stock Price Prediction.

BioCryst Pharmaceuticalsinvestment stock information. BioCryst Pharmaceuticals BCRX came out with a quarterly loss of 023 per share versus the Zacks Consensus Estimate of a loss of 032.

Biocryst Pharmaceuticals Inc Bcrx Stock Price Quote News Stock Analysis